Effect of quercetin on daunorubicin-induced heart mitochondria changes in rats

J Guzy1, J Kusnír, M Mareková

  • 1Department of Medical Chemistry and Biochemistry, Medical Faculty. Safarik University, Kosice, Slovak Republic.

Physiological Research
|December 4, 2003
PubMed

Insights

Quercetin, an antioxidant flavonoid, may protect against the heart damage caused by the cancer drug daunorubicin. This study shows quercetin helps maintain mitochondrial enzyme activity and membrane integrity during daunorubicin treatment.

Area of Science:

  • Biochemistry
  • Cardiology
  • Pharmacology

Background:

  • Cancer therapy with daunorubicin is limited by cardiotoxicity, potentially involving free radical generation and mitochondrial dysfunction.
  • Flavonoids with antioxidant properties are being investigated for their potential to prevent anthracycline-induced cardiotoxicity.

Purpose of the Study:

  • To investigate the effects of daunorubicin and quercetin on mitochondrial enzyme activities (ATPase, glutathione peroxidase (GPx), and glutathione reductase (GR)).
  • To assess changes in the outer mitochondrial membrane using synchronous fluorescence spectra.
  • To determine if quercetin can mitigate daunorubicin-induced cardiotoxicity.

Main Methods:

  • Enzyme activity assays for ATPase, GPx, and GR in the presence of daunorubicin and quercetin.
  • Synchronous fluorescence spectroscopy to analyze outer mitochondrial membrane changes.
  • Comparative analysis of enzyme activities and spectral data with and without quercetin pretreatment.

Main Results:

  • Daunorubicin significantly increased ATPase and GR activity, while decreasing GPx activity.
  • Quercetin pretreatment significantly alleviated the daunorubicin-induced increase in ATPase and GR activity.
  • Quercetin prevented the decrease in GPx activity and normalized daunorubicin-induced changes in outer mitochondrial membrane fluorescence.
  • Quercetin alone did not significantly affect enzyme activities.

Conclusions:

  • Quercetin demonstrates protective effects against daunorubicin-induced mitochondrial dysfunction.
  • Quercetin may be a potential therapeutic agent for mitigating daunorubicin-induced cardiotoxicity.
  • The findings support the role of quercetin as an antioxidant in preventing drug-induced heart damage.